Results 21 to 30 of about 94,588 (272)

Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab

SAGE Open Medical Case Reports, 2020
Certain diabetic and hypertensive patients started on intravitreal vascular endothelial growth factor inhibition for diabetic retinopathy may experience worsening of hypertension and proteinuria. The etiology of this is the newly recognized absorption of
R. Hanna, L. Abdelnour, H. Hasnain, U. Selamet, I. Kurtz   +4 more
semanticscholar   +1 more source

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis [PDF]

, 2021
Aim: To evaluate the efficacy of switching from bevacizumab to ranibizumab or aflibercept in eyes with diabetic macular edema (DME) unresponsive to bevacizumab.
Meireles, Angelina, Beirão, João Nuno Melo, Pessoa, Bernardete, Figueira, João, Melo Beirão, João Nuno, Figueira, João P, Coelho, João, Monteiro, Sílvia, Coelho, Constança, Beirão, João, Malheiro, Luísa, Carneiro, Inês   +11 more
core   +1 more source

Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema [PDF]

, 2010
Background: Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema. Methods and Materials: A collective of 32 patients, who had been treated
Haritoglou, Christos, Ulbig, Michael W., Kook, Daniel, Wolf, Armin, Neubauer, Aljoscha Steffen, Kreutzer, Thomas C., Al Saeidi, Rashid   +6 more
core   +1 more source

Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma [PDF]

, 2011
Purpose: To assess the duration of the effect of intracameral bevacizumab in patients presenting with rubeosis iridis and neovascular glaucoma (NVG). Methods: Retrospective analysis of 24 consecutive eyes of 24 patients with decompensated NVG (> 21 mm Hg)
Haritoglou, Christos, Wolf, Armin, Ulbig, Michael, Christos Haritoglou, Jagow, Burkhard von, Burkhard von Jagow, Michael Ulbig, Armin Wolf   +7 more
core   +1 more source

Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.

JAMA ophthalmology, 2019
Importance Radiation retinopathy following plaque radiotherapy for uveal melanoma can lead to vision loss that might be avoided with prophylactic anti-vascular endothelial growth factor treatment.
C. Shields, L. Dalvin, Michael Chang, M. Mazloumi, P. Fortin, M. McGarrey, Andrei Martin, Antonio Yaghy, Xiaolu Yang, P. Vichitvejpaisal, A. Mashayekhi, J. Shields   +11 more
semanticscholar   +1 more source

Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema [PDF]

, 2012
Purpose: To compare the efficacy and safety of three intravitreal bevacizumab upload injections followed by a dexamethasone implant versus dexamethasone implant monotherapy in eyes with macular edema due to retinal vein occlusion.
Haritoglou, Christos, Mayer, Wolfgang J., Wolf, Armin, Kook, Daniel, Ulbig, Michael, Reznicek, Lukas, Remy, Matthias, Kampik, Anselm   +7 more
core   +1 more source

Indications of Intravitreal Injection of Bevacizumab in a sample of Iraqi patients

مجله كليه طب الكندي, 2019
Background: Anti-vascular endothelial growth factors commonly used intravitreally for treatment of variable retinal disease worldwide, which help to regulate the upregulation of vascular endothelial growth factors due to ischemia or/and other retinal ...
Zaid R. Hussein
doaj   +1 more source

Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy

Case Reports in Ophthalmological Medicine, 2015
Purpose. To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment. Methods.
Eric K. Newcott, Abdallah A. Ellabban, Shokufeh Tavassoli, Ahmed Sallam   +3 more
doaj   +1 more source

Managing bevacizumab-induced intraocular inflammation

Indian Journal of Ophthalmology, 2012
The outcome of four cases of sterile endophthalmitis that developed after intravitreal injections of bevacizumab has been reported here. All four eyes received 1.25 mg/0.05 ml intravitreal bevacizumab from 0.2-ml aliquots for different etiologies.
Subijay Sinha, Nagender Vashisht, Pradeep Venkatesh, Sat Pal Garg   +3 more
doaj   +1 more source

Microperimetry and OCT angiography evaluation of patients with ischemic diabetic macular edema treated with monthly intravitreal bevacizumab: a pilot study

International Journal of Retina and Vitreous, 2019
Functional and anatomical evaluation of patients with ischemic diabetic macular edema after monthly injections of Bevacizumab. Five eyes from five patients with diabetic macular edema associated with macular ischemia in fluorescein angiography (FA ...
Felipe Pereira, Bruno Rebello Godoy, M. Maia, C. Regatieri   +3 more
semanticscholar   +1 more source